Testo Saveris, global leader in measurement solutions, has announced the latest software update for its testo Saveris 1 Environmental Monitoring System, designed to address the evolving needs of the ...

Rhenus Logistics has expanded its decade-long partnership with Testo Saveris to enhance the precision and reliability of pharmaceutical product storage and transport. With over 250 measurement points ...

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style. Instrumentation and measurement specialist Testo Saveris brings its ...

The Australian company H3D has completed a Series A financing round of 5.8 million US dollars. The round was led by Significant Ventures, with Swinburne University as the initial investor and Co:Act ...

Instrumentation and measurement specialist Testo Saveris is bringing its dedicated range of solutions for the pharmaceutical sector to CPHI, held in Frankfurt from 28 to 30 October. The company will ...

H3D co-founder and CTO Dr Philip Kinsella. Source: Supplied H3D, an AI-powered 3D printing startup creating custom healthcare products, has raised $5.8 million in a Series A. H3D emerged from ...

An AI-powered 3D printing startup creating custom healthcare products has raised $5.8 million in a Series A. H3D emerged from Swinburne University in 2018, its initial investor alongside Starfish ...

Every great scientific breakthrough starts the same way – with a question. This cycle – ask, explore, test, learn – aims to uncover truths from meticulous observation. In the case of drug discovery, ...

Swinburne University of Technology has invested in AI-driven technology for dental devices based on Swinburne PhD research. The investment in technology company H3D, will support the commercialisation ...

Swinburne University of Technology is putting its money where your mouth is, investing in AI-driven technology for dental devices based on Swinburne PhD research, following similar success in the ...

Tuberculosis (TB) is the world’s deadliest infectious disease. In 2023, about 10.8 million people contracted TB, and 1.25 million people died from it, according to the World Health Organization.